To evaluate NRF2-dependent regulation of these genes, we generated two KEAP1 -mutant NSCLC cell lines (A549 and NCI-H460) stably integrated with a doxycycline (dox)-inducible shRNA targeting NRF2
Next-Generation Therapies Shift toward oral GLP-1 pills (no injections) Development of dual and triple agonists (GLP-1 + GIP combinations) Expansion into cardiovascular, kidney, and metabolic diseases 3
264,268 Released at the guts end, GLP-1 acts on its receptors in the gastrointestinal tract, leading to reduced gastric muscle contractions and extended food retention in the stomach
People were losing more weight
Allergic reaction: Symptoms include swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, and a rapid heartbeat
This ensures the B12 shots work well